Bronislava Gedulin - Concepedia

Author

Bronislava Gedulin

Also Known As

B Gedulin, B R Gedulin, B. Gedulin, B. R. Gedulin, B.R. Gedulin, BRONISLAVA GEDULIN, Bronislava Gedulin, Bronislava R Gedulin, Bronislava R. Gedulin, Gedulin, B.

Publications

Citations

H-Index

Concepts

All Affiliations

Amplyx Pharmaceuticals (United States)GlaxoSmithKline (United States)NeuroGenetic Pharmaceuticals (United States)Research Triangle Park Foundation

About

Bronislava Gedulin is an author at Amplyx Pharmaceuticals (United States) specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	21	2.1K
2	Diabetes	13	13	1.4K
3	Health Sciences	10	10	1.2K
4	Biochemistry	8	8	498
5	Public Health	1	1	149

Bronislava Gedulin

Publications

Citations

H-Index

Page 1

	Year	Citations
Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Andrew A. Young, Bronislava Gedulin, Sunil Bhavsar, Diabetes	1999	442
Exenatide (Exendin-4) Improves Insulin Sensitivity and β-Cell Mass in Insulin-Resistant Obese<i>fa/fa</i>Zucker Rats Independent of Glycemia and Body Weight Bronislava Gedulin, Svetlana E. Nikoulina, Pam Smith, Endocrinology NutritionMetabolic DisorderCon RatsEx RatsInsulin Signaling	2004	239
Effects of PYY[3–36] in rodent models of diabetes and obesity Richard Pittner, Candace X. Moore, Sunil Bhavsar, International Journal of Obesity ObesityCaloric RestrictionMetabolic SyndromeEnergy HomeostasisMetabolic Disorder	2004	219
Dose-response for glucagonostatic effect of amylin in rats Bronislava Gedulin, T J Rink, Andrew A. Young Metabolism MedicineGlucagonostatic EffectPhysiologyExperimental PharmacologyGlucocorticoid	1997	178
Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin Andrew A. Young, Bronislava Gedulin, William Vine, Diabetologia Metabolic SyndromeDiabetic Bb RatsSubcutaneous InjectionsMedicinePhysiology	1995	177
Preliminary report Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake Andrew A. Young, Bronislava Gedulin, T J Rink Metabolism Animal PhysiologyNutritionPreliminary Report Dose-responsesNutrient UptakeGastrointestinal Pharmacology	1996	149
Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers Thomas E. Adrian, Salah Gariballa, Khatija Parekh, Diabetologia ObesityMetabolic SyndromeNutritionPhysiologyDiabetes	2012	144
Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin Andrew A. Young, William Vine, Bronislava Gedulin, Drug Development Research Experimental PharmacologyInsulin SignalingType Ii DiabetesTranslational PharmacologyGastrointestinal Peptide Hormone	1996	133
Effects of rectal administration of taurocholic acid on glucagon‐like peptide‐1 and peptide <scp>YY</scp> secretion in healthy humans Tongzhi Wu, Michelle J. Bound, Scott Standfield, Diabetes Obesity and Metabolism	2012	121
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight Christine M. Mack, Carlos José Soares, Julie Wilson, International Journal of Obesity NutritionNovel Amylin-mimetic PeptideBiochemistryNative AmylinMedicine	2009	110

Page 1